Representatives from Broncus Medical Inc strike the gong to announce the company's listing on the Hong Kong Exchanges and Clearing Market on Sept 24. [Photo/zj.zjol.com.cn]

Founded in 2012, Broncus Medical specializes in developing interventional pulmonology products and provides innovative solutions to lung diseases. The medical company has developed the first and only pneumology platform, which can help treat most pulmonary diseases, in China.

Broncus Medical Inc, which is based in the Hangzhou Hi-tech Industrial Development Zone (Binjiang district), was listed on the mainboard of the Hong Kong Stock Exchange on Sept 24, 2021.